Assembly Biosciences Inc

NASDAQ:ASMB   4:00:00 PM EDT
18.09
-0.47 (-2.53%)
5:25:09 PM EDT: $18.09 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)138.17M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.3 Million
Adjusted EPS-$1.73
See more estimates
10-Day MA$17.89
50-Day MA$15.10
200-Day MA$14.39
See more pivots

Assembly Biosciences Inc Stock, NASDAQ:ASMB

Two Tower Place, 7th floor, South San Francisco, California 94080
United States of America
Phone: +1.833.509.4583
Number of Employees: 65

Description

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.